Uses of Ecomin

What is Ecomin? The drug has the main ingredient is methylcobalamin and the excipients are just enough to help ensure the volume, solubility, and stability of Ecomin. On the market, Ecomin is available in dosage forms with the following concentrations:
Ecomin - OD 1500 mcg oral form. Ecomin - OD 1500 mcg/1ml intramuscular injection. With the main ingredient is methylcobalamin - this is a coenzyme form of vitamin B12 found in blood and cerebrospinal fluid, methylcobalamin is transported into nerve tissue higher than other forms of vitamin B12. Studies have also shown that methylcobalamin restores damaged nerve tissue and blocks the conduction of abnormal nerve impulses. Therefore, Ecomin is often indicated for use in the following specific cases:
Treatment of peripheral neuropathies such as neuropathy caused by alcoholism, drugs, and diabetes. Patients with neuralgia due to occupational disease, movement, and exercise. Treatment of megaloblastic anemia caused by vitamin B12 deficiency, preventing oxidation, especially preventing atherosclerosis and toxicity caused by free radicals and chemicals. In addition, Ecomin is also indicated in some other cases when prescribed by a doctor. Ecomin should not be used in the following patients
Patients with a history of allergy or hypersensitivity to any of the ingredients of Ecomin. Patients with malignant neoplasms because methylcobalamin promotes tissue growth with a high growth rate, so there is a risk of tumor progression.

Ecomin is used according to the doctor's prescription. The dosage of Ecomin can be referred to as follows:
Dosage of Ecomin for adults with peripheral neuropathy:
Ecomin taken orally: 1 tablet/time x 1 time/day. Ecomin drug used by intramuscular injection: 1 ampoule/day, intramuscular injection 3 times/week. Dosage of Ecomin to treat megaloblastic anemia in adults: 1 ampoule/day, intramuscular injection 3 times/week. After about 2 months of treatment, reduce the dose of Ecomin to a maintenance dose of 1-3 months, repeat injection of 1 ampoule.

Ecomin medicine can cause unwanted effects for users. However, this is not the case with all patients taking the drug. Common side effects include: itching, rash, diarrhea.

Currently, the safety of Ecomin drug for pregnant women has not been determined and it is not clear whether Ecomin is excreted in breast milk, so it is necessary to use caution when using Ecomin for pregnant women and for pregnant women. Breastfeeding, Ecomin should only be used in this group of subjects when absolutely necessary, considering the benefits outweigh the risks. Ecomin should not be used for many months if no effect is seen after a period of treatment. Ecomin is not recommended for use in infants, premature infants and infants. Ecomin is easily decomposed by light, so after opening the tube, it must be used immediately, do not let light shine directly on the medicine. Follow the correct intramuscular injection technique, determine the correct injection site to avoid unwanted effects on tissues and nerves. Avoid multiple intramuscular injections into the same place, be very cautious when administering Ecomin intramuscularly to children. Ecomin is well tolerated, no significant interactions have been noted. Store Ecomin at room temperature below 30°C, in a cool, dry place, away from light and reach of children.